Localised deep microwave hyperthermia in the treatment of benign prostatic hyperplasia: long-term assessment.
A group of 133 patients with benign prostatic hyperplasia who were either poor operative risks or who had refused surgery underwent localised deep microwave hyperthermia, without supplementary drugs. In 59% of patients who had had an indwelling catheter, freedom from urological obstruction and satisfactory voiding were maintained for 7 years and catheterisation was not required. In patients with severe prostatic symptoms, 65% showed general improvement and satisfactory voiding for 8 years. There were no side effects. Patients who relapsed were given a second course of treatment and 75% responded positively. This positive response and the lack of side effects suggest that localised deep microwave hyperthermia may be an effective alternative to surgery in the management of high risk patients and those who are reluctant to undergo surgery.
Yerushalmi
A
A
Department of Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Singer
D
D
Katsnelson
R
R
Levy
E
E
Shani
A
A
D000368:Aged; D000369:Aged, 80 and over; D005500:Follow-Up Studies; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods*; D008297:Male; D008872:Microwaves / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000628:therapy*; D014524:Urethral Obstruction / Q000628:therapy